GUCY2C molecular staging personalizes colorectal cancer patient management.

Gong JP, Schulz S, Hyslop T, Waldman SA. GUCY2C molecular staging personalizes colorectal cancer patient management. Biomark Med. 2012 Jun; 6(3):339-48.

View in: PubMed